IRS Issues Final Rule Implementing Medical Device Excise Tax
The Internal Revenue Service released a
implementing a Patient Protection and Affordable Care Act provision that imposes on certain medical devices made after 2012 an excise tax equal to 2.3% of their sales price. In submitted on the proposed rule AHRMM, the American Hospital Association and others urged the IRS to explicitly prohibit device companies from passing the tax on to customers, and to clarify that hospitals and other healthcare providers who package and sterilize devices for use in surgery kits should not be treated as device manufacturers or importers under the rule. The final rule does not address AHRMM’s recommendation that manufacturers certify that the tax has not been passed on to customers, but provides that current rules apply in determining the sales price of items. Also, of importance, the final rule states that a kit produced by a hospital or medical institution for its own use would not be a taxable medical device.Related Resources
Sponsored White Papers
What does it take to eliminate $57M in supply chain leakage? See how a 14-hospital system did it—without adding burden to clinicians.
White Papers
Discover how interpreter quality, workflow integration, and technology alignment impact total cost of care, compliance readiness, and staff…
e-Learning
Explore strategies to achieve customer service excellence, the 12 steps of strategic planning and the impact of regulations, recalls and…
Education & Events
Learn essential health care supply chain purchasing principles, including sourcing, contracting, negotiation, and product selection to balance cost,…
Book
AHRMM's Policies and Procedures Manual for the Health Care Supply Chain, 2nd Edition contains over 160 new and revised health care supply chain…